Figure 1From: High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer Expression of p-Smad2 in stromal fibroblasts and in cancer cells by immunohistochemistry in non-small cell lung cancer (NSCLC) (magnification × 200). Back to article page